Related Experiment Video
Updated: Dec 30, 2025

Modeling Spontaneous Metastatic Renal Cell Carcinoma mRCC in Mice Following Nephrectomy
Published on: April 29, 2014
Membrane type-2 matrix metalloproteinases improve the progression of renal cell cancer
Yiming Chen1, Hao Lu1, Ding Tao1
1Department of Urology, The Third Affiliated Hospital of Soochow University 185 Juqian Street, Changzhou 213003, People's Republic of China.
Abstract:
Matrix metalloproteinases (MMPs) are a family of proteolytic enzymes, which involved in the degradation of extracellular matrix (ECM) and basement membrane (BM), and associated with tumor invasion and metastasis. Membrane type-2 MMP (MT2-MMP) is a member of MT-MMPs subgroup, and is supposed to be an important step for cancer invasion and metastasis. However, the roles of MT2-MMP in human renal cell carcinoma (RCC) remain unknown. In present study, we identified the roles of MT2-MMP in renal cancer progression by MT2-MMP suppression and overexpression in ACHN cells, which expressed highest level of MT2-MMP and lowest level of MT1-MMP in three kinds of renal cancer cells (786-0, ACHN, OS-RC-2). We found that the expression of MMP-2 could be regulated by MT2-MMP suppression or overexpression in ACHN cells, and both adhesion and invasive activities of ACHN cells were suppressed with MT2-MMP siRNA transfection. In addition, we found that MT2-MMP could increase ACHN cell proliferation, and inhibit cell apoptosis. In vitro tumor growth experiment showed that MT2-MMP could increase clone formation of ACHN cells. The results indicated that MT2-MMP could promoter renal cancer cell invasion and adhesion by activating the expression of MMP2, and stimulate tumor growth of renal cancer.
Insights
Matrix metalloproteinases (MT2-MMP) promote renal cell carcinoma (RCC) invasion and growth. Suppressing MT2-MMP in ACHN cells reduced invasion, adhesion, and proliferation, while inhibiting apoptosis.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Matrix metalloproteinases (MMPs) degrade extracellular matrix, aiding tumor invasion and metastasis.
- Membrane type-2 MMP (MT2-MMP) is implicated in cancer progression, but its role in renal cell carcinoma (RCC) is unclear.
Purpose of the Study:
- To investigate the role of MT2-MMP in the progression of human renal cell carcinoma (RCC).
Main Methods:
- MT2-MMP expression was suppressed and overexpressed in ACHN renal cancer cells.
- MMP-2 expression, cell adhesion, invasion, proliferation, and apoptosis were analyzed.
- In vitro tumor growth was assessed via clone formation assays.
Main Results:
- MT2-MMP expression levels varied among RCC cell lines, with ACHN cells showing high MT2-MMP.
- MT2-MMP suppression or overexpression modulated MMP-2 expression in ACHN cells.
- MT2-MMP significantly enhanced ACHN cell proliferation, adhesion, invasion, and clone formation, while inhibiting apoptosis.
Conclusions:
- MT2-MMP promotes renal cell carcinoma (RCC) invasion and adhesion by activating MMP-2.
- MT2-MMP stimulates tumor growth in renal cancer by increasing proliferation and inhibiting apoptosis.
Related Concept Videos
Role of Matrix Metalloproteases in Degradation of ECM
The Tumor Microenvironment
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Extracellular Matrix
In order to maintain tissue organization, many animal cells are surrounded by structural molecules that make up the extracellular matrix (ECM). Together, the molecules in the ECM maintain the structural integrity of tissue as well as the remarkable specific properties of certain tissues.
Composition of the Extracellular Matrix
The extracellular matrix (ECM) is commonly composed of ground substance, a gel-like fluid, fibrous components, and many structurally and functionally diverse...

